2/2
01:32 pm
aort
Artivion (NYSE:AORT) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $58.00 price target on the stock.
Low
Report
Artivion (NYSE:AORT) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $58.00 price target on the stock.
2/2
08:33 am
aort
Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting [Yahoo! Finance]
Medium
Report
Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting [Yahoo! Finance]
2/2
08:00 am
aort
Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting
Low
Report
Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting
2/1
04:21 pm
aort
Artivion (AORT) Valuation Check After Recent Share Price Moves And Growth Outlook [Yahoo! Finance]
Medium
Report
Artivion (AORT) Valuation Check After Recent Share Price Moves And Growth Outlook [Yahoo! Finance]
1/29
04:05 pm
aort
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results
Low
Report
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results
1/27
09:03 am
aort
2 Stocks Under $50 to Research Further and 1 We Avoid [Yahoo! Finance]
Medium
Report
2 Stocks Under $50 to Research Further and 1 We Avoid [Yahoo! Finance]
1/24
03:01 am
aort
Low
Report
1/23
05:06 am
aort
Artivion (NYSE:AORT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Artivion (NYSE:AORT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/13
06:40 am
aort
1 Profitable Stock with Exciting Potential and 2 Facing Headwinds [Yahoo! Finance]
Low
Report
1 Profitable Stock with Exciting Potential and 2 Facing Headwinds [Yahoo! Finance]
1/5
07:42 am
aort
Assessing Artivion (AORT) Valuation After Strong Recent Returns And Ongoing Net Loss [Yahoo! Finance]
Low
Report
Assessing Artivion (AORT) Valuation After Strong Recent Returns And Ongoing Net Loss [Yahoo! Finance]
1/5
06:50 am
aort
1 Healthcare Stock on Our Watchlist and 2 We Ignore [Yahoo! Finance]
Low
Report
1 Healthcare Stock on Our Watchlist and 2 We Ignore [Yahoo! Finance]
12/29
02:07 pm
aort
Artivion Continues Building Toward Bigger And Better Things [Seeking Alpha]
Low
Report
Artivion Continues Building Toward Bigger And Better Things [Seeking Alpha]
12/29
10:16 am
aort
1 Safe-and-Steady Stock on Our Watchlist and 2 We Avoid [Yahoo! Finance]
Low
Report
1 Safe-and-Steady Stock on Our Watchlist and 2 We Avoid [Yahoo! Finance]
12/21
01:08 am
aort
Low
Report
12/18
07:28 am
aort
3 Cash-Producing Stocks with Questionable Fundamentals [Yahoo! Finance]
Low
Report
3 Cash-Producing Stocks with Questionable Fundamentals [Yahoo! Finance]
12/17
04:15 pm
aort
Artivion (AORT) Stock Is Up, What You Need To Know [Yahoo! Finance]
Low
Report
Artivion (AORT) Stock Is Up, What You Need To Know [Yahoo! Finance]
12/17
07:06 am
aort
Artivion (NYSE:AORT) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Low
Report
Artivion (NYSE:AORT) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
11/27
02:33 pm
aort
Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Low
Report
Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
11/26
06:07 am
aort
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Artivion (NYSE:AORT) Vs The Rest [Yahoo! Finance]
Low
Report
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Artivion (NYSE:AORT) Vs The Rest [Yahoo! Finance]
11/15
07:05 pm
aort
Strong Q3 Results and Raised Outlook Could Be a Game Changer for Artivion (AORT) [Yahoo! Finance]
Low
Report
Strong Q3 Results and Raised Outlook Could Be a Game Changer for Artivion (AORT) [Yahoo! Finance]
11/11
09:26 am
aort
2 Unpopular Stocks That Deserve a Second Chance and 1 Facing Challenges [Yahoo! Finance]
Medium
Report
2 Unpopular Stocks That Deserve a Second Chance and 1 Facing Challenges [Yahoo! Finance]